Qvanteq obtained government funding in the form of a new CTI/KTI project (19305.1 PFLS-LS)

The topic of this 18 month program is the “Investigation of in vitro response of human blood to Qvanteq’s anti-thrombotic and pro-healing surface technology applied on vascular stents”.